GlassScriptPhysician profile
George Russell
NPI 1508307448
$1,028.07
in general payments reported to CMS, 2019-2025
17 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.48 · 2020: $43.07 · 2021: $148 · 2022: $177 · 2023: $222 · 2024: $176 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $283.49 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $150.58 | 2023-2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $107.55 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $105.01 | 2021-2024 | |
| Novo Nordisk INC | $66.01 | 2024-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $48.78 | 2020-2023 | M-M-R II, Rotateq, Vaxelis |
| Glaxosmithkline, LLC. | $41.41 | 2022-2023 | Trelegy Ellipta |
| Mylan Specialty L.P. | $39.59 | 2019-2022 | |
| Dexcom, INC. | $39.00 | 2023-2025 | Dexcom G6 Transmitter |
| Organon LLC | $21.97 | 2022-2023 | Nexplanon |
| Sanofi Pasteur INC. | $21.86 | 2022 | |
| Gilead Sciences, INC. | $19.58 | 2020 | |
| Sunovion Pharmaceuticals INC. | $18.85 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.17 | 2021 | |
| Antares Pharma, INC. | $16.70 | 2025 | Xyosted |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $15.78 | 2025 | |
| Melinta Therapeutics, LLC | $13.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.